North America Market Study on Synthetic Opioids

Publish Date: May 2017

Report Code: PMR253A

Publisher: Persistence Market Research

Single User License: $4900

Explore Our Services

Already a member? Login here.

Report Highlights

Manufacturers of opioids have witnessed tremendous growth in consumption in the last decade. This stupendous growth can be attributed to the absence of regulatory policies and lack of product knowledge among physicians. However, the scenario has changed and now, companies are facing challenges from reformed regulations. Hence, in order to sustain in such a regulatory environment, companies are now focusing on the development of more advanced forms of opioids that strictly adhere to the prescription and manufacturing regulations. In a new report on the North America synthetic opioids market titled “North America Synthetic Opioids Market: Global Industry Analysis and Forecast 2016-2024,” the analysts of Persistence Market Research have observed that pharmaceutical companies are highly focused on the development of tamper evident opioid drugs, owing to the high misuse of opioids. Companies are taking measures to develop non-abuse drug formulations to prohibit the misuse of opioids. For example, in July 2014, the U.S. Food and Drug Administration approved the newer form of OxyContin, a type of non-abuse opioid drug. The report further states that the U.S market holds the maximum share of opioid sales. After phenomenal growth in opioid sales, the market has become stagnant over the past few years, due to several regulations and restrictions on prescription drugs.

North America Synthetic Opioids Market: Average Selling Price Analysis 2015

Average selling price of Buprenorphine is higher among all the drugs because of the high cost of transdermal patches. Fentanyl transdermal patches also increases its per mg average selling price
The prices of opioid drugs have decreased because of the increased generic availability of the products
Average selling price is the most important parameter in determining the revenue generated by the particular drug by multiplying it with the average per capita consumption of the drug in North America
Average drug pricing is nearly similar in both U.S and Canada
Report Structure

The analysts have segmented the North America synthetic opioids market into four categories namely by country, by product type, by application and by distribution channel. The report begins with the executive summery and extensively covers the market overview, overall market approach, target geographies and differentiating strategies of key players in the North America synthetic opioids market. The executive summery is followed by the market introduction and consists of the definition of various types of products in the North America synthetic opioids market. The analysts have covered detailed analysis of the North America synthetic opioids market scenario. This analysis includes Y-o-Y growth and absolute $ opportunity for the forecast period. Various market dynamics that comprise drivers, restraints, opportunities and trends are covered in the report. The analysts have made sure to cover each and every segment in detail along with highlighting the market share analysis, BPS analysis and the Y-o-Y growth rate of the North America synthetic opioids market. The report concludes with key player profiles accompanied by key developments, business strategy overview and SWOT analysis.

Market Segmentation

By Country

U.S
Canada
By Product Type

Synthetic Opioids
Methadone
Fentanyl
Meperidine
Semi-Synthetic Opioids
Hydrocodone
Oxymorphone
Oxycodone
Hydromorphone
Buprenorphine
By Application

Pain Management
De-addiction
By Distribution Channel

Retail Outlet
Hospitals
Research Methodology

The analysts have considered the weighted average pricing of different opioids in North America while inspecting this market. Generic products have been taken into account, as an increase in generic products has led to a decrease in the average pricing of the drugs. Patented formulations such as tamper-resistant drugs or controlled release drugs are differentiated products and thus charge a high price; hence, they affect the average selling price of the product. Various government agencies regulate the selling prices of drugs and thus affect the price of many branded products. A demand-supply gap analysis has been carried out involving both marketplace discussion and desk research to determine the price. Indicators such as R&D expenditure, research funding from government and non-profit organizations etc. have been considered to arrive at the indicated market numbers. The analysts have not factored yearly change in inflation rate while forecasting market numbers. All values for market size are in US$ (US Dollar).

  • Table 1 : North America Synthetic Opioids Market Value (US$ Bn) Analysis and Forecast by Component, 2016�2024
  • Table 2 : North America Synthetic Opioids Market Value (US$ Bn) Analysis and Forecast by Application, 2016�2024
  • Table 3 : North America Synthetic Opioids Market Value (US$ Mn) Analysis and Forecast by Distribution Channel, 2016�2024
  • Table 4 : North America Synthetic Opioids Market Value (US$ Mn) Analysis and Forecast by Country, 2016�2024
  • Table 5 : U.S Synthetic Opioids Market Value (US$ Bn) Analysis and Forecast by Component, 2016�2024
  • Table 6 : U.S. Synthetic Opioids Market Value (US$ Mn) Analysis and Forecast by Application, 2016�2024
  • Table 7 : U.S Synthetic Opioids Market Value (US$ Mn) Analysis and Forecast by Distribution Channel, 2016�2024
  • Table 8 : U.S Synthetic Opioids Market Value (US$ Mn) Analysis and Forecast by Component, 2016�2024
  • Table 9 : Canada Intraoperative Imaging Market Value (US$ Mn) Analysis and Forecast by Application, 2016�2024
  • Table 10 : Canada Synthetic Opioids Market Value (US$ Mn) Analysis and Forecast by Distribution Channel, 2016�2024
  • Figure 1 : North America Synthetic & Semi synthetic Opioids Average Selling Price (per mg)
  • Figure 2 : North America Synthetic Opioids Market Value (US$ Bn) & Y-o-Y Growth (%), 2016-2024
  • Figure 3 : North America Synthetic Opioids Market Absolute $ Opportunity, 2016-2024
  • Figure 4 : North America Synthetic & Semi synthetic Opioids Per Capita Consumption (mg)
  • Figure 5 : Top 10 US States with Highest Opioid Prescription
  • Figure 6 : Sources of Opioid Painkillers in North America
  • Figure 7 : North America Synthetic Opioids Market Share Analysis (%) by Product Type, 2016 & 2024
  • Figure 8 : North America Synthetic Opioids Y-o-Y growth (%) by Product Type, 2016-2024
  • Figure 9 : North America Synthetic Opioids Market Value (US$ Bn) & Y-o-Y Growth (%) by Synthetic Opioids, 2016-2024
  • Figure 10 : North America Synthetic Opioids Market Absolute $ Opportunity by Synthetic Opioids, 2016-2024
  • Figure 11 : North America Synthetic Opioids Market Value (US$ Bn) & Y-o-Y Growth (%) by Semi-Synthetic Opioids, 2016-2024
  • Figure 12 : North America Synthetic Opioids Market Absolute $ Opportunity by Semi-Synthetic Opioids, 2016-2024
  • Figure 13 : North America Synthetic Opioids Market Attractiveness Analysis by Product Type, 2016-2024
  • Figure 14 : North America Synthetic Opioids Market Share Analysis (%) by Application, 2016-2024
  • Figure 15 : North America Synthetic Opioids Y-o-Y growth (%) by Application, 2016-2024
  • Figure 16 : North America Synthetic Opioids Market Value (US$ Bn) & Y-o-Y Growth (%) by Pain Management Segment, 2016-2024
  • Figure 17 : North America Synthetic Opioids Market Absolute $ Opportunity by Pain Management Segment, 2016-2024
  • Figure 18 : North America Synthetic Opioids Market Value (US$ Bn) & Y-o-Y Growth (%) by De-addiction Segment, 2016-2024
  • Figure 19 : North America Synthetic Opioids Market Absolute $ Opportunity by De-addiction Segment, 2016-2024
  • Figure 20 : North America Synthetic Opioids Market Attractiveness Analysis by Application Type, 2016-2024
  • Figure 21 : North America Synthetic Opioids Market Share Analysis (%) by Distribution Channel, 2016 & 2024
  • Figure 22 : North America Synthetic Opioids Y-o-Y growth (%) by Distribution Channel, 2016-2024
  • Figure 23 : North America Synthetic Opioids Market Value (US$ Bn) & Y-o-Y Growth (%) by Retail Outlets Segment, 2016-2024
  • Figure 24 : North America Synthetic Opioids Market Absolute $ Opportunity by Retail Outlets Segment, 2016-2024
  • Figure 25 : North America Synthetic Opioids Market Value (US$ Bn) & Y-o-Y Growth (%) by Hospitals Segment, 2016-2024
  • Figure 26 : North America Synthetic Opioids Market Absolute $ Opportunity by Hospitals Segment, 2016-2024
  • Figure 27 : North America Synthetic Opioids Market Attractiveness Analysis by Distribution Channel, 2016-2024
  • Figure 28 : North America Synthetic Opioids Market Share Analysis (%) by Country, 2016 & 2024
  • Figure 29 : North America Synthetic Opioids Market Y-o-Y growth (%) by Country, 2016-2024
  • Figure 30 : U.S. Synthetic Opioids Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2024
  • Figure 31 : U.S. Synthetic Opioids Market Absolute $ Opportunity, 2016-2024
  • Figure 32 : Canada Synthetic Opioids Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2024
  • Figure 33 : Canada Synthetic Opioids Market Absolute $ Opportunity, 2016-2024
  • Figure 34 : North America Synthetic Opioids Market Attractiveness Analysis by Country, 2016-2024
  • Figure 35 : U.S. Synthetic Opioids Market Share Analysis (%) by Product Type, 2016 & 2024
  • Figure 36 : U.S Synthetic Opioids Market Y-o-Y growth (%) by Product Type, 2016-2024
  • Figure 37 : U.S. Synthetic Opioids Market Share Analysis (%) by Application, 2016 & 2024
  • Figure 38 : U.S Synthetic Opioids Market Y-o-Y growth (%) by Application, 2016-2024
  • Figure 39 : U.S. Synthetic Opioids Market Share Analysis (%) by Distribution Channel, 2016 & 2024
  • Figure 40 : U.S Synthetic Opioids Market Y-o-Y growth (%) by Distribution Channel, 2016-2024
  • Figure 41 : U.S Synthetic Opioids Market Attractiveness Analysis by Product Type, 2016-2024
  • Figure 42 : U.S Synthetic Opioids Market Attractiveness Analysis by Application, 2016-2024
  • Figure 43 : U.S Synthetic Opioids Market Attractiveness Analysis by Distribution Channel, 2016-2024
  • Figure 44 : Canada Synthetic Opioids Market Share Analysis (%) by Product Type, 2016 & 2024
  • Figure 45 : Canada Synthetic Opioids Market Y-o-Y growth (%) by Product Type, 2016-2024
  • Figure 46 : Canada Synthetic Opioids Market Share Analysis (%) by Application, 2016 & 2024
  • Figure 47 : Canada Synthetic Opioids Market Y-o-Y growth (%) by Application, 2016-2024
  • Figure 48 : Canada Synthetic Opioids Market Share Analysis (%) by Distribution Channel, 2016 & 2024
  • Figure 49 : Canada Synthetic Opioids Market Y-o-Y growth (%) by Distribution Channel, 2016-2024
  • Figure 50 : Canada Synthetic Opioids Market Attractiveness Analysis by Product Type, 2016-2024
  • Figure 51 : Canada Synthetic Opioids Market Attractiveness Analysis by Application, 2016-2024
  • Figure 52 : Canada Synthetic Opioids Market Attractiveness Analysis by Distribution Channel, 2016-2024

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
North America Market Study on Synthetic Opioids